To test or to not test: A retrospective cross-sectional study on potentially inappropriate use of pathology testing in South Australian hospitals.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Oxford University Press Country of Publication: England NLM ID: 0370470 Publication Model: Print Cited Medium: Internet ISSN: 1943-7722 (Electronic) Linking ISSN: 00029173 NLM ISO Abbreviation: Am J Clin Pathol Subsets: MEDLINE
    • Publication Information:
      Publication: 2016- : Oxford : Oxford University Press
      Original Publication: Philadelphia [etc.] Lippincott [etc.]
    • Subject Terms:
    • Abstract:
      Objectives: To measure rates of potentially inappropriate pathology testing in the hospital setting.
      Methods: Retrospective cross-sectional study in hospital setting from July 2021 to December 2021. We examined 3 potentially inappropriate uses: overordering, selection errors, and unnecessary repeat testing. Overordering included vitamin D and lipids (rarely required in acute hospital care). Selection error was the ratio of iron studies to standalone ferritin requests. Unnecessary repeats included any repeat vitamin D, lipids, iron, or ferritin in an episode of care or C-reactive protein (CRP) repeated within 3 days and N-terminal pro-brain natriuretic peptide (NT-proBNP) within 7 days and repeated previously abnormal CRP and NT-proBNP tests. Costs of inappropriate tests were estimated using the Australian Medicare Benefits Schedules.
      Results: Among 55,904 test requests, 15% (n = 8120) were potentially inappropriate. Vitamin D was frequently ordered (n = 4498), as were lipids (n = 2872). Ratio of iron studies to standalone ferritin was 36. Of 19,233 repeat CRPs, 36% (n = 6947) were within 3 days and 62% (n = 179) of repeat NT-proBNPs were within 7 days of the first test. For initially abnormal tests, 89% of CRPs and 97% of NT-proBNPs remained abnormal. Inappropriate test costs accounted for 12% to 30% of costs.
      Conclusions: Frequent potential inappropriate use and selection of pathology tests was observed in South Australian hospitals.
      (© American Society for Clinical Pathology, 2023.)
    • References:
      J Am Heart Assoc. 2020 Dec 15;9(24):e018897. (PMID: 33289416)
      BMJ Open Qual. 2020 Feb;9(1):. (PMID: 32098778)
      Mayo Clin Proc. 2010 Aug;85(8):752-7; quiz 757-8. (PMID: 20675513)
      BMJ Open. 2018 Sep 12;8(9):e023117. (PMID: 30209159)
      Ann Med Surg (Lond). 2020 Feb 07;51:48-53. (PMID: 32082564)
      PLoS One. 2013 Nov 15;8(11):e78962. (PMID: 24260139)
      JAMA. 1998 Aug 12;280(6):550-8. (PMID: 9707147)
      Int J Health Care Qual Assur. 2013;26(6):510-21. (PMID: 24003751)
      Biochem Med (Zagreb). 2022 Jun 15;32(2):020701. (PMID: 35464748)
      Heart Lung Circ. 2016 Sep;25(9):895-951. (PMID: 27476580)
      Clin Biochem Rev. 2017 Nov;38(3):107-114. (PMID: 29332975)
      Clin Case Rep. 2018 Apr 17;6(6):1082-1086. (PMID: 29881569)
      Anaesth Intensive Care. 2018 May;46(3):313-320. (PMID: 29716490)
      Cureus. 2019 Oct 9;11(10):e5872. (PMID: 31763095)
      Arch Pathol Lab Med. 2014 Apr;138(4):505-11. (PMID: 24678681)
      Ann Intern Med. 2004 Aug 3;141(3):196-204. (PMID: 15289216)
      Front Immunol. 2018 Apr 13;9:754. (PMID: 29706967)
      Cureus. 2019 Jun 18;11(6):e4930. (PMID: 31431836)
      Am J Med. 2016 Jan;129(1):116.e1-116.e34. (PMID: 26169890)
      Med J Aust. 2013 Dec 16;199(11):813-4. (PMID: 24329676)
      Circulation. 2003 Sep 23;108(12):e81-5. (PMID: 14504253)
      Front Immunol. 2018 Jun 07;9:1302. (PMID: 29951057)
      J Am Heart Assoc. 2022 Apr 19;11(8):e025294. (PMID: 35383469)
      Heart. 2006 Jun;92(6):843-9. (PMID: 16698841)
    • Grant Information:
      Hospital Research Foundation Group
    • Contributed Indexing:
      Keywords: clinical laboratory services; clinical pathology; education; hospital care; informatics; management/administration; medical laboratory science; quality
    • Accession Number:
      114471-18-0 (Natriuretic Peptide, Brain)
      9007-41-4 (C-Reactive Protein)
      9007-73-2 (Ferritins)
      0 (Peptide Fragments)
      1406-16-2 (Vitamin D)
      E1UOL152H7 (Iron)
      0 (Lipids)
      0 (Biomarkers)
    • Publication Date:
      Date Created: 20231117 Date Completed: 20240404 Latest Revision: 20240426
    • Publication Date:
      20240426
    • Accession Number:
      PMC10988106
    • Accession Number:
      10.1093/ajcp/aqad153
    • Accession Number:
      37975596